35 Results for "

Solid tumours

" in MedChemExpress (MCE) Product Catalog:
Products (35)

35 Results for "Solid tumours" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-P99176

Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

ATG-031 is a humanized anti-CD24 monoclonal antibody with high affinity and specificity. ATG-031 interacts with Siglec-10 expressed by tumor-associated macrophages. ATG-031 effectively stimulates macrophage-mediated phagocytosis and induces cancer cell destruction by blocking the anti-phagocytic surface proteins. ATG-031 can be used in the study of haematological malignancies as well as solid tumors. Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control (HY-P99003) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-13432
CAS No.: 1256448-47-1
Purity:  99.34%
Synonyms: CHR-3996
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

Nanatinostat (CHR-3996) is a potent, class I selective and orally active HDAC inhibitor with IC50s of 3 nM, 4 nM, and 7 nM for HDAC1, HDAC2, and HDAC3, respectively. Nanatinostat has low activity against HDAC5 (IC50 of 200 nM) and HDAC6 (IC50 of 2100 nM). Nanatinostat induces apoptosis in myeloma cells. Nanatinostat has potent anticancer effects, such as myeloma, advanced solid tumours and colorectal cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P99011
CAS No.: 1855925-27-7
Synonyms: RG-7802; RO-6958688; CEA-TCB

Target:  

CD3

Research Areas:  

Cancer

Cibisatamab, a T cell bispecific antibody, binds Carcino-Embryonic Antigen (CEA) on cancer cells and CD3 on T cells. Cibisatamab triggers T cell killing of cancer cell lines expressing moderate to high levels of CEA at the cell surface. Cibisatamab can be used for colorectal cancer research .
loading...
    loading...
Cat. No.: HY-172320
CAS No.: 2919596-13-5
Target:  

PD-1/PD-L1

Research Areas:  

Cancer

BMS-986238 is an orally active macrocyclic peptide PD-L1 inhibitor. BMS-986238 can be used in the research of tumors such as solid tumors and lymphomas .
loading...
    loading...
Cat. No.: HY-150314
CAS No.: 1685273-57-7
Purity:  99.74%
Research Areas:  

Cancer

MCT-IN-1 (Compound 2) is a potent MCT inhibitor, with IC50 values of 9 nM and 14 nM against MCT1 and MCT4, respectively. MCT-IN-1 can be used in research related to solid tumors .
loading...
    loading...
Cat. No.: HY-P99450
CAS No.: 2226393-85-5
Synonyms: IPH 5401; Anti-C5aR1 mAb

Target:  

Complement System

Research Areas:  

Inflammation/Immunology Cancer

Avdoralimab (IPH 5401) is a fully human IgGκ monoclonal antibody that targets the complement C5a receptor 1 (C5aR1) that prevents its binding to C5a. Avdoralimab can be used for complement-driven inflammatory diseases and solid tumours research .
loading...
    loading...
Cat. No.: HY-P99114
CAS No.: 2256084-03-2

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

Sugemalimab is a fully human, full length, anti-programmed death ligand 1 (PD-L1) immunoglobulin G4 (IgG4) monoclonal antibody (mAb). Sugemalimab shows anticancer activities and can be used for non-small cell lung cancer research .
loading...
    loading...
Cat. No.: HY-176761
CAS No.: 1033931-92-8
Research Areas:  

Cancer

NSC647889 is an apoptosis and autophagy inducer. NSC647889 induces apoptosis, inhibits mTOR pathway and abrogates DNA synthesis. NSC647889 triggers LC3-positive vesicle formation, modulates AKT and 4EBP1 phosphorylation and shows heightened caspase-3 activation in multicellular spheroids. NSC647889 can be used for the research of solid cancer tumour, head-neck carcinoma, and colorectal cancer .
loading...
    loading...
Cat. No.: HY-118953
CAS No.: 270902-51-7
Target:  

MetAP Drug Intermediate

Research Areas:  

Cancer

LAF389, a prodrug of LAF153 (HY-183876), is a methionine aminopeptidase (MetAps) inhibitor with an IC50 of 800 nM against MetAp2, and exhibits a maximum inhibition rate of 20% against MetAp1 at 300 nM. LAF389 possesses antiproliferative, antiangiogenic and cytotoxic activities. LAF389 can be used in research related to cancers such as advanced solid tumors .
loading...
    loading...
Cat. No.: HY-139678
CAS No.: 2839142-69-5
SC13 is an orally active, selective Flap structure-specific endonuclease 1 (FEN1) inhibitor and mu opioid receptor (MOR) activator. SC13 impairs DNA damage repair and induces apoptosis in cancer cells. SC13 activates cGAS-STING signaling, increases chemokine secretion, and promotes CAR-T cell infiltration at solid tumour sites. SC13 can be used for the research of solid tumours and pain .
loading...
    loading...
Cat. No.: HY-P99035
CAS No.: 1412892-09-1

Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology Cancer

Naptumomab is a fusion protein of a tumor-targeting superantigen (TTS). Naptumomab stimulates the immune system to recognize and kill tumor cells and can be used in the study of refractory solid tumors such as renal cell carcinoma .
loading...
    loading...
Cat. No.: HY-P991469
Synonyms: MEDI-565

Research Areas:  

Cancer

AMG-211 (MEDI-565)i s a bispecific antibody targeting CD3E and CEACAM5/CEA/CD66e. AMG-211 can be used in Gastrointestinal cancer and Solid tumours research .
loading...
    loading...
Cat. No.: HY-139453A
CAS No.: 2412580-47-1
Research Areas:  

Cancer

LP-284 is a potent DNA alkylating agent that kills solid tumours. LP-284 can be used in the studies of hematologic cancers with compromised DNA repair, such as mantle cell lymphoma (MCL) .
loading...
    loading...
Cat. No.: HY-111786
CAS No.: 1258595-14-0
Purity:  ≥98.0%
Research Areas:  

Cancer

LHC-165 is a TLR7 agonist. LHC-165 has potential to used in study of solid tumors .
loading...
    loading...
Cat. No.: HY-148954
CAS No.: 1620909-95-6
Research Areas:  

Cancer

PBF-999 is a phosphodiesterase10A (PDE-10A) and adenosine A2A receptor (A2AR) dual antagonist.
loading...
    loading...
Cat. No.: HY-P99867
CAS No.: 1204390-13-5
Synonyms: MEDI 573

Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

Dusigitumab is a fully human IgG2λ monoclonal antibody that targets IGF-1 and IGF-2 with picomolar binding affinity. Dusigitumab blocks IGF-1 and IGF-2-induced phosphorylation of IGF-1R as well as activation of IR-A, thereby inhibiting the activation of downstream signaling pathways. Dusigitumab is applicable to research related to advanced solid tumors and hormone receptor-positive metastatic breast cancer .
loading...
    loading...
Cat. No.: HY-P991348

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

BAT-1306 is a human monoclonal antibody (mAb) targeting PDCD1/PD-1/CD279. BAT-1306 can be used in Colorectal cancer and Solid tumours research .
loading...
    loading...
Cat. No.: HY-P991391

Research Areas:  

Cancer

COM902 is a human IgG4 monoclonal antibody (mAb) targeting TIGIT. COM902 enhances anti-tumor immune responses. COM902 can be used in Multiple myeloma, Solid tumours and Colorectal cancer research. Recommended isotype control: IgG4-lambda .
loading...
    loading...
Cat. No.: HY-P991560
CAS No.: 2987103-72-8

Target:  

CD47

Research Areas:  

Cancer

TQB-2928 is a monoclonal antibody against CD47, which can be used in the study of cancer.
loading...
    loading...
Cat. No.: HY-128470
CAS No.: 91753-07-0
Synonyms: GR-30921
Target:  

Drug Derivative

Research Areas:  

Cancer

Mitoquidone (GR-30921) is is the first member of a group of pentacyclic pyrroloquinones. Mitoquidone shows good activity in a range of experimental solid tumour models. Mitoquidone can be used for the research of anti-cancer .
loading...
    loading...